Herpesvirus-encoded G protein-coupled receptors as modulators of cellular function

Molecular Pharmacology

Volumn 76, Issue 4, 2009, Pages 692-701

  Maussang, David ^a   Vischer, Henry F ^a   Leurs, Rob ^a   Smit, Martine J ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; G PROTEIN COUPLED RECEPTOR;

ANTIVIRAL THERAPY; ATHEROSCLEROSIS; AUTOCRINE EFFECT; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL TRANSFORMATION; DIMERIZATION; DRUG TARGETING; GENOME; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; NONHUMAN; OPEN READING FRAME; PARACRINE SIGNALING; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; ATHEROSCLEROSIS; DIMERIZATION; GENOME, VIRAL; HERPESVIRIDAE; HUMANS; OPEN READING FRAMES; RECEPTOR CROSS-TALK; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 70349320151     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.057091     Document Type: Short Survey

References (102)

1. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, and Cesarman E (1997) Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385:347-350. (Pubitemid 27053105)
2. Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, Asch AS, Cesarman E, Gershengorn MC, Mesri EA, et al. (1998) G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391:86-89. (Pubitemid 28079220)
3. Bais C, Van Geelen A, Eroles P, Mutlu A, Chiozzini C, Dias S, Silverstein RL, Rafii S, and Mesri EA (2003) Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. Cancer Cell 3:131-143. (Pubitemid 37443386)
4. Bakker RA, Casarosa P, Timmerman H, Smit MJ, and Leurs R (2004) Constitutively active Gq/11-coupled receptors enable signaling by co-expressed G(i/o)-coupled receptors. J Biol Chem 279:5152-5161. (Pubitemid 38220532)
5. Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4:540-550.
6. Beisser PS, Verzijl D, Gruijthuijsen YK, Beuken E, Smit MJ, Leurs R, Bruggeman CA, and Vink C (2005) The Epstein-Barr virus BILF1 gene encodes a G protein-coupled receptor that inhibits phosphorylation of RNA-dependent protein kinase. J Virol 79:441-449. (Pubitemid 39648397)
7. Billstrom MA, Johnson GL, Avdi NJ, and Worthen GS (1998) Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection. J Virol 72:5535-5544. (Pubitemid 28283336)
8. Bodaghi B, Jones TR, Zipeto D, Vita C, Sun L, Laurent L, Arenzana-Seisdedos F, Virelizier JL, and Michelson S (1998) Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med 188:855-866. (Pubitemid 28433412)
9. Boomker JM, de Jong EK, de Leij LF, and Harmsen MC (2006) Chemokine scavenging by the human cytomegalovirus chemokine decoy receptor US28 does not inhibit monocyte adherence to activated endothelium. Antiviral Res 69:124-127.
10. Brunovskis P and Kung HJ (1995) Retrotransposition and herpesvirus evolution. Virus Genes 11:259-270.
11. Cannon ML and Cesarman E (2004) The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells. Oncogene 23:514-523.
12. Casarosa P, Bakker RA, Verzijl D, Navis M, Timmerman H, Leurs R, and Smit MJ (2001) Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28. J Biol Chem 276:1133-1137. (Pubitemid 32096538)
13. Casarosa P, Menge WM, Minisini R, Otto C, van Heteren J, Jongejan A, Timmerman H, Moepps B, Kirchhoff F, Mertens T, et al. (2003) Identification of the first nonpeptidergic inverse agonist for a constitutively active viral-encoded G protein-coupled receptor. J Biol Chem 278:5172-5178. (Pubitemid 36801029)
14. Case R, Sharp E, Benned-Jensen T, Rosenkilde MM, Davis-Poynter N, and Farrell HE (2008) Functional analysis of the murine cytomegalovirus chemokine receptor homologue M33: ablation of constitutive signaling is associated with an attenuated phenotype in vivo. J Virol 82:1884-1898. (Pubitemid 351222436)
15. Caselli E and Di Luca D (2007) Molecular biology and clinical associations of Roseoloviruses human herpesvirus 6 and human herpesvirus 7. New Microbiol 30:173-187. (Pubitemid 47264876)
16. Catusse J, Spinks J, Mattick C, Dyer A, Laing K, Fitzsimons C, Smit MJ, and Gompels UA (2008) Immunomodulation by herpesvirus U51A chemokine receptor via CCL5 and FOG-2 down-regulation plus XCR1 and CCR7 mimicry in human leukocytes. Eur J Immunol 38:763-777.
17. Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS, Chang Y, and Knowles DM (1996) Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol 70:8218-8223. (Pubitemid 26339142)
18. Chaisuparat R, Hu J, Jham BC, Knight ZA, Shokat KM, and Montaner S (2008) Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma. Cancer Res 68:8361-8368.
19. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, and Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
20. Chee MS, Satchwell SC, Preddie E, Weston KM, and Barrell BG (1990) Human cytomegalovirus encodes three G protein-coupled receptor homologues. Nature 344:774-777. (Pubitemid 20120609)
21. Chen R, Xiong S, Yang Y, Fu W, Wang Y, and Ge J (2003) The relationship between human cytomegalovirus infection and atherosclerosis development. Mol Cell Biochem 249:91-96. (Pubitemid 37021034)
22. Chiou CJ, Poole LJ, Kim PS, Ciufo DM, Cannon JS, ap Rhys CM, Alcendor DJ, Zong JC, Ambinder RF, and Hayward GS (2002) Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J Virol 76:3421-3439.
23. Christensen T (2007) Human herpesviruses in MS. Int MS J 14:41-47.
24. Cinatl J Jr, Cinatl J, Vogel JU, Rabenau H, Kornhuber B, and Doerr HW (1996) Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology 39:259-269. (Pubitemid 27105489)
25. Cinatl J, Scholz M, Kotchetkov R, Vogel JU, and Doerr HW (2004) Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology. Trends Mol Med 10:19-23. (Pubitemid 38156195)
26. Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, and Britt WJ (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347-3350. (Pubitemid 34651375)
27. Colman R and Blackbourn DJ (2008) Risk factors in the development of Kaposi's sarcoma. AIDS 22:1629-1632.
28. Ferré S, Baler R, Bouvier M, Caron MG, Devi LA, Durroux T, Fuxe K, George SR, Javitch JA, Lohse MJ, et al. (2009) Building a new conceptual framework for receptor heteromers. Nat Chem Biol 5:131-134.
29. Fitzsimons CP, Gompels UA, Verzijl D, Vischer HF, Mattick C, Leurs R, and Smit MJ (2006) Chemokine-directed trafficking of receptor stimulus to different g proteins: selective inducible and constitutive signaling by human herpesvirus 6-encoded chemokine receptor U51. Mol Pharmacol 69:888-898. (Pubitemid 43363863)
30. Fraile-Ramos A, Kledal TN, Pelchen-Matthews A, Bowers K, Schwartz TW, and Marsh M (2001) The human cytomegalovirus US28 protein is located in endocytic vesicles and undergoes constitutive endocytosis and recycling. Mol Biol Cell 12: 1737-1749. (Pubitemid 33049726)
31. Gao JL and Murphy PM (1994) Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J Biol Chem 269:28539-28542.
32. García MA, Gil J, Ventoso I, Guerra S, Domingo E, Rivas C, and Esteban M (2006) Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70:1032-1060. (Pubitemid 44958263)
33. Geras-Raaka E, Varma A, Clark-Lewis I, and Gershengorn MC (1998a) Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF- 1alpha inhibit signaling by KSHV G protein-coupled receptor. Biochem Biophys Res Commun 253:725-727. (Pubitemid 29039209)
34. Geras-Raaka E, Varma A, Ho H, Clark-Lewis I, and Gershengorn MC (1998b) Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J Exp Med 188:405-408. (Pubitemid 28357769)
35. Gershengorn MC, Geras-Raaka E, Varma A, and Clark-Lewis I (1998) Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J Clin Invest 102:1469-1472. (Pubitemid 28492212)
36. Grisotto MG, Garin A, Martin AP, Jensen KK, Chan P, Sealfon SC, and Lira SA (2006) The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells. J Clin Invest 116:1264-1273.
37. Gruijthuijsen YK, Casarosa P, Kaptein SJ, Broers JL, Leurs R, Bruggeman CA, Smit MJ, and Vink C (2002) The rat cytomegalovirus R33-encoded G protein-coupled receptor signals in a constitutive fashion. J Virol 76:1328-1338. (Pubitemid 34066435)
38. Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI, and Cobbs CS (2002) Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 360:1557-1563. (Pubitemid 35356371)
39. Ho HH, Ganeshalingam N, Rosenhouse-Dantsker A, Osman R, and Gershengorn MC (2001) Charged residues at the intracellular boundary of transmembrane helices 2 and 3 independently affect constitutive activity of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J Biol Chem 276:1376-1382. (Pubitemid 32096568)
40. Holst PJ, Rosenkilde MM, Manfra D, Chen SC, Wiekowski MT, Holst B, Cifire F, Lipp M, Schwartz TW, and Lira SA (2001) Tumorigenesis induced by the HHV8- encoded chemokine receptor requires ligand modulation of high constitutive activity. J Clin Invest 108:1789-1796. (Pubitemid 34015124)
41. Horváth R, Cerný J, Benedík J Jr, Hökl J, Jelínková I, and Benedík J (2000) The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol 16:17-24.
42. Hulshof JW, Casarosa P, Menge WM, Kuusisto LM, van der Goot H, Smit MJ, de Esch IJ, and Leurs R (2005) Synthesis and structure-activity relationship of the first nonpeptidergic inverse agonists for the human cytomegalovirus encoded chemokine receptor US28. J Med Chem 48:6461-6471. (Pubitemid 41428998)
43. Hulshof JW, Vischer HF, Verheij MH, Fratantoni SA, Smit MJ, de Esch IJ, and Leurs R (2006) Synthesis and pharmacological characterization of novel inverse agonists acting on the viral-encoded chemokine receptor US28. Bioorg Med Chem 14:7213-7230.
44. Isegawa Y, Ping Z, Nakano K, Sugimoto N, and Yamanishi K (1998) Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor. J Virol 72:6104-6112. (Pubitemid 28283400)
45. Jensen KK, Manfra DJ, Grisotto MG, Martin AP, Vassileva G, Kelley K, Schwartz TW, and Lira SA (2005) The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma. J Immunol 174:3686-3694. (Pubitemid 40354079)
46. Kaptein SJ, Beisser PS, Gruijthuijsen YK, Savelkouls KG, van Cleef KW, Beuken E, Grauls GE, Bruggeman CA, and Vink C (2003) The rat cytomegalovirus R78 G protein-coupled receptor gene is required for production of infectious virus in the spleen. J Gen Virol 84:2517-2530. (Pubitemid 37063142)
47. Kledal TN, Rosenkilde MM, and Schwartz TW (1998) Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28. FEBS Lett 441:209-214.
48. Kuhn DE, Beall CJ, and Kolattukudy PE (1995) The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. Biochem Biophys Res Commun 211:325-330.
49. Kurata H, Lee HJ, McClanahan T, Coffman RL, O'Garra A, and Arai N (2002) Friend of GATA is expressed in naive Th cells and functions as a repressor of GATA-3- mediated Th2 cell development. J Immunol 168:4538-4545. (Pubitemid 34441358)
50. Levoye A, Dam J, Ayoub MA, Guillaume JL, Couturier C, Delagrange P, and Jockers R(2006a) The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization. EMBO J 25:3012-3023. (Pubitemid 44106754)
51. Levoye A, Dam J, Ayoub MA, Guillaume JL, and Jockers R(2006b) Do orphan G-protein-coupled receptors have ligand-independent functions? New insights from receptor heterodimers. EMBO Rep 7:1094-1098. (Pubitemid 44660563)
52. Liu C, Sandford G, Fei G, and Nicholas J (2004) Galpha protein selectivity determinant specified by a viral chemokine receptor-conserved region in the C tail of the human herpesvirus 8 g protein-coupled receptor. J Virol 78:2460-2471. (Pubitemid 38228939)
53. Mackay CR (2001) Chemokines: immunology's high impact factors. Nat Immunol 2:95-101.
54. Manning BD, Tee AR, Logsdon MN, Blenis J, and Cantley LC (2002) Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell 10:151-162. (Pubitemid 34876569)
55. Mariani L, Löhning M, Radbruch A, and Höfer T (2004) Transcriptional control networks of cell differentiation: insights from helper T lymphocytes. Prog Biophys Mol Biol 86:45-76. (Pubitemid 38946554)
56. Marinissen MJ and Gutkind JS (2001) G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22:368-376. (Pubitemid 32592476)
57. Martin D, Galisteo R, Ji Y, Montaner S, and Gutkind JS (2008) An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia. Oncogene 27:1844-1852.
58. Maussang D, Langemeijer E, Fitzsimons CP, Stigter-van Walsum M, Dijkman R, Borg MK, Slinger E, Schreiber A, Michel D, Tensen CP, et al. (2009) The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2. Cancer Res 69:2861-2869.
59. Maussang D, Verzijl D, van Walsum M, Leurs R, Holl J, Pleskoff O, Michel D, van Dongen GA, and Smit MJ (2006) Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci U S A 103:13068-13073. (Pubitemid 44338917)
60. McLean KA, Holst PJ, Martini L, Schwartz TW, and Rosenkilde MM (2004) Similar activation of signal transduction pathways by the herpesvirus-encoded chemokine receptors US28 and ORF74. Virology 325:241-251. (Pubitemid 38902790)
61. Melnychuk RM, Smith P, Kreklywich CN, Ruchti F, Vomaske J, Hall L, Loh L, Nelson JA, Orloff SL, and Streblow DN (2005) Mouse cytomegalovirus M33 is necessary and sufficient in virus-induced vascular smooth muscle cell migration. J Virol 79:10788-10795. (Pubitemid 41098617)
62. Michaelis M, Doerr HW, and Cinatl J (2009) The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia 11:1-9.
63. Michel D, Milotić I, Wagner M, Vaida B, Holl J, Ansorge R, and Mertens T (2005) The human cytomegalovirus UL78 gene is highly conserved among clinical isolates, but is dispensable for replication in fibroblasts and a renal artery organ-culture system. J Gen Virol 86:297-306. (Pubitemid 40227940)
64. Miller G (2009) Brain cancer. A viral link to glioblastoma? Science 323:30-31.
65. Milligan G (2006) G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery. Drug Discov Today 11:541-549.
66. Milne RS, Mattick C, Nicholson L, Devaraj P, Alcami A, and Gompels UA (2000) RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokine receptor. J Immunol 164:2396-2404. (Pubitemid 30115467)
67. Mokros T, Rehm A, Droese J, Oppermann M, Lipp M, and Höpken UE (2002) Surface expression and endocytosis of the human cytomegalovirus-encoded chemokine receptor US28 is regulated by agonist-independent phosphorylation. J Biol Chem 277:45122-45128. (Pubitemid 36159114)
68. Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y, Li Y, Ray PE, and Gutkind JS (2003) Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3:23-36. (Pubitemid 37443889)
69. Montaner S, Sodhi A, Pece S, Mesri EA, and Gutkind JS (2001) The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res 61:2641-2648. (Pubitemid 32685850)
70. Montaner S, Sodhi A, Ramsdell AK, Martin D, Hu J, Sawai ET, and Gutkind JS (2006) The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Cancer Res 66:168-174. (Pubitemid 43166022)
71. Oliveira SA and Shenk TE (2001) Murine cytomegalovirus M78 protein, a G protein-coupled receptor homologue, is a constituent of the virion and facilitates accumulation of immediate-early viral mRNA. Proc Natl Acad Sci U S A 98:3237-3242.
72. Pati S, Cavrois M, Guo HG, Foulke JS Jr, Kim J, Feldman RA, and Reitz M (2001) Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J Virol 75:8660-8673. (Pubitemid 32768970)
73. Paulsen SJ, Rosenkilde MM, Eugen-Olsen J, and Kledal TN (2005) Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor. J Virol 79:536-546. (Pubitemid 39648406)
74. Penfold ME, Schmidt TL, Dairaghi DJ, Barry PA, and Schall TJ (2003) Characterization of the rhesus cytomegalovirus US28 locus. J Virol 77:10404-10413.
75. Pleskoff O, Casarosa P, Verneuil L, Ainoun F, Beisser P, Smit M, Leurs R, Schneider P, Michelson S, and Ameisen JC (2005) The human cytomegalovirus- encoded chemokine receptor US28 induces caspase-dependent apoptosis. FEBS J 272:4163-4177. (Pubitemid 41160923)
76. Rosenkilde MM, Kledal TN, Bräuner-Osborne H, and Schwartz TW (1999) Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seventransmembrane oncogene product, ORF-74. J Biol Chem 274:956-961. (Pubitemid 129535257)
77. Rosenkilde MM, Kledal TN, Holst PJ, and Schwartz TW (2000) Selective elimination of high constitutive activity or chemokine binding in the human herpesvirus 8 encoded seven transmembrane oncogene ORF74. J Biol Chem 275:26309-26315.
78. Samanta M, Harkins L, Klemm K, Britt WJ, and Cobbs CS (2003) High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol 170:998-1002. (Pubitemid 36999620)
79. Shepard LW, Yang M, Xie P, Browning DD, Voyno-Yasenetskaya T, Kozasa T, and Ye RD (2001) Constitutive activation of NF-kappa B and secretion of interleukin-8 induced by the G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus involve G alpha(13) and RhoA.. J Biol Chem 276:45979-45987. (Pubitemid 37370843)
80. Smit MJ, Verzijl D, Casarosa P, Navis M, Timmerman H, and Leurs R (2002) Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor ORF74 constitutively activates p44/p42 MAPK and Akt via G(i) and phospholipase C-dependent signaling pathways. J Virol 76:1744-1752. (Pubitemid 34094621)
81. Smit MJ, Vischer HF, Bakker RA, Jongejan A, Timmerman H, Pardo L, and Leurs R (2007) Pharmacogenomic and structural analysis of constitutive g proteincoupled receptor activity. Annu Rev Pharmacol Toxicol 47:53-87. (Pubitemid 46272124)
82. Söderberg-Nauclér C (2006) Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med 259:219-246.
83. Söderberg-Nauclér C (2008) HCMV microinfections in inflammatory diseases and cancer. J Clin Virol 41:218-223.
84. Sodhi A, Chaisuparat R, Hu J, Ramsdell AK, Manning BD, Sausville EA, Sawai ET, Molinolo A, Gutkind JS, and Montaner S (2006) The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Cancer Cell 10:133-143. (Pubitemid 44175903)
85. Sodhi A, Montaner S, Patel V, Gómez-Román JJ, Li Y, Sausville EA, Sawai ET, and Gutkind JS (2004) Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. Proc Natl Acad Sci U S A 101:4821-4826. (Pubitemid 38469161)
86. Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA, and Gutkind JS (2000) The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor upregulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res 60:4873-4880. (Pubitemid 30701503)
87. Springael JY, Urizar E, Costagliola S, Vassart G, and Parmentier M (2007) Allosteric properties of G protein-coupled receptor oligomers. Pharmacol Ther 115:410-418. (Pubitemid 47362379)
88. Streblow DN, Kreklywich CN, Smith P, Soule JL, Meyer C, Yin M, Beisser P, Vink C, Nelson JA, and Orloff SL (2005) Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33. Am J Transplant 5:436-442. (Pubitemid 40313334)
89. Streblow DN, Soderberg-Naucler C, Vieira J, Smith P, Wakabayashi E, Ruchti F, Mattison K, Altschuler Y, and Nelson JA (1999) The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 99:511-520.
90. Streblow DN, Vomaske J, Smith P, Melnychuk R, Hall L, Pancheva D, Smit M, Casarosa P, Schlaepfer DD, and Nelson JA (2003) Human cytomegalovirus chemokine receptor US28-induced smooth muscle cell migration is mediated by focal adhesion kinase and Src. J Biol Chem 278:50456-50465. (Pubitemid 37548891)
91. Sullivan RJ, Pantanowitz L, Casper C, Stebbing J, and Dezube BJ (2008) HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin Infect Dis 47:1209-1215.
92. Tadagaki K, Nakano K, and Yamanishi K (2005) Human herpesvirus 7 open reading frames U12 and U51 encode functional beta-chemokine receptors. J Virol 79:7068-7076. (Pubitemid 40677338)
93. Turini ME and DuBois RN (2002) Cyclooxygenase-2: a therapeutic target. Annu Rev Med 53:35-57.
94. Vischer HF, Leurs R, and Smit MJ (2006a) HCMV-encoded G-protein-coupled receptors as constitutively active modulators of cellular signaling networks. Trends Pharmacol Sci 27:56-63. (Pubitemid 43063125)
95. Vischer HF, Nijmeijer S, Smit MJ, and Leurs R (2008) Viral hijacking of human receptors through heterodimerization. Biochem Biophys Res Commun 377:93-97.
96. Vischer HF, Vink C, and Smit MJ (2006b) A viral conspiracy: hijacking the chemokine system through virally encoded pirated chemokine receptors. Curr Top Microbiol Immunol 303:121-154.
97. Vomaske J, Melnychuk RM, Smith PP, Powell J, Hall L, DeFilippis V, Früh K, Smit M, Schlaepfer DD, Nelson JA, et al. (2009) Differential ligand binding to a human cytomegalovirus chemokine receptor determines cell type-specific motility. PLoS Pathog 5:e1000304.
98. Waldhoer M, Casarosa P, Rosenkilde MM, Smit MJ, Leurs R, Whistler JL, and Schwartz TW (2003) The carboxyl terminus of human cytomegalovirus-encoded 7 transmembrane receptor US28 camouflages agonism by mediating constitutive endocytosis. J Biol Chem 278:19473-19482. (Pubitemid 36799344)
99. Waldhoer M, Kledal TN, Farrell H, and Schwartz TW (2002) Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities. J Virol 76:8161-8168. (Pubitemid 34809070)
100. Yang TY, Chen SC, Leach MW, Manfra D, Homey B, Wiekowski M, Sullivan L, Jenh CH, Narula SK, Chensue SW, et al. (2000) Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191:445-454. (Pubitemid 30693569)
101. Yap TA, Garrett MD, Walton MI, Raynaud F, de Bono JS, and Workman P (2008) Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises. Curr Opin Pharmacol 8:393-412.
102. Zuo J, Currin A, Griffin BD, Shannon-Lowe C, Thomas WA, Ressing ME, Wiertz EJ, and Rowe M (2009) The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation. PLoS Pathog 5:e1000255.